Skip to content
Screener

National Health Investors NHI Q4 2025 Annual earnings

Reported February 26, 2026 · After market close

Revenue$70.3MBeat by $1.2M
EPS$1.22Beat by $0.42
Revenue estimate$69.0M
EPS estimate$0.80

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$68.5M
EPS estimate$1.16

Financials

Q4 2025

Income statement

See full
Revenue$105.8M+23.4%
Net income$38.2M-11.7%
EPS (diluted)$0.80-16.7%

Balance sheet

See full
Cash & equivalents$19.6M-26.0%
Total debt$1.2B+1.5%
Total equity$1.5B+11.3%
Total assets$2.8B+7.0%

Cash flow

See full
Operating cash flow$67.7M+17.7%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$3.64B+15.6%
Enterprise value$4.78B+12.1%
P/E25.6×+2.8×
P/S9.7×+0.3×

Profitability

See full
Net margin37.9%-3.3pp

Returns & leverage

See full
Return on equity9.8%-0.7pp
Debt / equity0.8×-0.1×

Segments

By segment

See full
Investments$75.2M+5.0%
SHOP$30.7M+119%

FAQ

When did National Health Investors report Q4 2025 earnings?
National Health Investors (NHI) reported Q4 2025 earnings on February 26, 2026 after market close.
What were National Health Investors's Q4 2025 revenue and EPS?
National Health Investors reported revenue of $70.3M and eps of $1.22 for Q4 2025.
Did National Health Investors beat estimates in Q4 2025?
Revenue beat the consensus estimate of $69.0M by $1.2M. EPS beat the consensus estimate of $0.80 by $0.42.
How did National Health Investors's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 18.0% from $85.8M a year earlier and eps grew 8.0% from $1.13.
Where can I find National Health Investors's Q4 2025 SEC filings?
You can read the 8-K earnings release (0000877860-26-000030) and the 10-K periodic report (0000877860-26-000053) directly on SEC EDGAR. The filing index links above go to sec.gov.